<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>17</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>04</Month>
        <Day>28</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Imbalance of Peripheral Blood T Helper Type 17 Responses in Patients with Vitiligo</title>
    <FirstPage>171</FirstPage>
    <LastPage>178</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Farinaz</FirstName>
        <LastName>Behfarjam</LastName>
        <affiliation locale="en_US">Department&#xA0; of&#xA0; Clinical Genetics, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Parvine</FirstName>
        <LastName>Mansouri</LastName>
        <affiliation locale="en_US">Department of Dermatology, Skin and Stem Cell Research Center, Tehran University of&#xA0;Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zohreh</FirstName>
        <LastName>Jadali</LastName>
        <affiliation locale="en_US">Department of Dermatology, Skin and Stem Cell Research Center, Tehran University of&#xA0;Medical Sciences, Tehran, Iran AND Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>04</Month>
        <Day>09</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>06</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">There is growing evidence to suggest that Th cells play pivotal roles in a variety of chronic inflammatory diseases, including vitiligo. However, the exact role of different subsets of Th cells in the pathogenesis of vitiligo is still a question. The purpose of present study was to determine the mRNA expression level of Th17 master transcription factor retinoic acid receptor-related orphan receptors gamma (ROR&#x263;t) and cytokine mRNA and protein expression profiles of Th17 cells. 22 patients with vitiligo and 22 normal subjects were enrolled in the study. Gene expression profiles of freshly isolated peripheral blood mononuclear cells (PBMCs) were determined by quantitative real-time reverse transcriptase PCR (qRT-PCR). Plasma concentrations of IL-17A and IL-22 were also assayed using ELISA kits. The results showed that ROR&#x263;t, IL-17A and IL-22 mRNA expression were increased in patients remarkably compared to healthy controls (p&lt;0.05). Furthermore, plasma IL-17A and IL-22 levels were also higher in vitiligo patients versus controls (p&lt;0.001). These data suggest that a deregulated Th17 adaptive immune response may contribute to the pathogenesis of vitiligo.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1405</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/1405/818</pdf_url>
  </Article>
</Articles>
